Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of febuxostat in sepsis
IRCT20230814059148N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of febuxostat in sepsis, sponsored by Tabriz University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
febuxostat
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20230814059148N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230814059148N1.